Continuous variables | Values |
---|---|
Subjects, n | 193 |
Age in years | 77.6 (3.2) |
Education, age at leaving school | 15.2 (2.8) |
Body mass index in kg/m2 | 26.8 (3.5) |
Systolic blood pressure, mm Hg | 158.4 (22.3) |
Diastolic blood pressure, mm Hg | 83.6 (10.0) |
Fasting glucose, mmol/L | 5.9 (1.7) |
Total cholesterol, mmol/L | 5.0 (1.1) |
High density lipoprotein cholesterol, mmol/L | 1.3 (0.4) |
Triglycerides, mmol/L | 1.4 (0.7) |
Baseline mini mental state examination score, points | 28.4 (2.1) |
Baseline stroop test score, seconds | 56.6 (23.4) |
Immediate picture-word learning test score, words | 10.1 (2.1) |
Delayed picture-word learning test, words | 10.9 (3.0) |
Letter-digit coding test score, digits/min | 26.0 (7.0) |
MRI features | Â |
Grey matter in mL | 465.6 (59.1) |
White matter in mL | 609.3 (70.2) |
Brain atrophy, percentage | 26.1 (3.2) |
White matter hyperintensity volume in mL | 5.1 (9.5) |
Categorical variables | Â |
Male, n (%) | 105 (54) |
Current smoking, n (%) | 28 (15) |
History of diabetes mellitus, n (%) | 41 (21) |
History of transient ischemic attack or stroke, n (%) | 29 (18) |
 Ischemic cortical infarction, n (%) | 7 (4) |
 Lacunar infarction, n (%) | 9 (5) |
History of myocardial infarction, n (%) | 28 (15) |
Use of anticholinergics, n (%) | 10 (5) |
Use of antiepileptics, n (%) | 0 (0) |
Use of antipsychotics, n (%) | 0 (0) |
Use of benzodiazepines, n (%) | 10 (5) |